- Investing Ideas
- /
- Global Pharmaceuticals & Biotech High Return On Equity, Low Debt
Global Pharmaceuticals & Biotech High Return On Equity, Low Debt
Results
20
0 new
Stocks with a return on equity of over 30% and a debt to equity ratio below 1.
20 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
MEDP | US$337.35 | 1.9% | 12.8% | US$10.5b | US$343.23 | PE28.6x | E10.9% | n/a | ||
ORNBV | €48.85 | 9.6% | 12.4% | €6.9b | €50.50 | PE20.7x | E9.2% | 3.3% | ||
500488 | ₹27,660.05 | -3.1% | 9.8% | ₹587.8b | ₹28,688.57 | PE45.8x | E11.2% | 1.5% | ||
688278 | CN¥80.28 | 12.1% | 50.4% | CN¥32.7b | CN¥87.23 | PE44.1x | E31.7% | 0.5% | ||
500660 | ₹2,136.20 | 2.2% | -5.9% | ₹361.9b | ₹2,914.50 | PE53.6x | E16.4% | 1.5% | ||
PTGX | US$36.82 | -0.9% | 47.3% | US$2.2b | US$57.10 | PE12.8x | E0.9% | n/a | ||
AGIO | US$32.42 | -2.7% | 49.3% | US$1.8b | US$57.00 | PE2.7x | E-29.8% | n/a | ||
MDXG | US$9.12 | 5.9% | 8.4% | US$1.3b | US$13.40 | PE16.9x | E-1.9% | n/a | ||
500126 | ₹5,491.80 | 5.7% | 5.4% | ₹91.2b | n/a | PE41.9x | E11.3% | 2.2% | ||
JSLL | ₹2,217.60 | 1.6% | 238.3% | ₹55.1b | n/a | PE65.4x | n/a | 0.2% | ||
HVO | UK£0.18 | 8.5% | -31.2% | UK£121.8m | UK£0.34 | PE7x | E-29.6% | 1.1% | ||
GRIN | CA$0.88 | -2.2% | 125.6% | CA$197.8m | n/a | PE35.4x | n/a | n/a | ||
93M1 | €23.00 | 0.9% | 42.4% | €98.5m | €108.00 | PE0.8x | E-65.7% | 5.2% | ||
INDSWFTLAB | ₹111.98 | 11.0% | 4.6% | ₹6.6b | n/a | PE1.8x | n/a | n/a | ||
EZZ | AU$2.24 | -10.0% | 273.3% | AU$103.4m | AU$5.45 | PE14.8x | E17.9% | 1.3% | ||
A067290 | ₩1,523.00 | -0.7% | -27.3% | ₩81.1b | n/a | PE11x | n/a | 0% | ||
6817 | NT$90.60 | -0.1% | -7.4% | NT$1.7b | n/a | PE11.1x | n/a | 7.3% | ||
690 | HK$0.06 | -1.6% | -34.8% | HK$358.3m | n/a | PE3.6x | n/a | n/a | ||
SCNI | US$3.51 | 2.6% | -37.3% | US$3.0m | n/a | PE0.6x | n/a | n/a | ||
CPTR | CA$0.69 | 0% | -42.5% | CA$2.4m | n/a | PE0.1x | n/a | n/a |
Page 1 of 1